Show simple item record

dc.contributor.authorTran, Truc T.
dc.contributor.authorJaijakul, Siraya
dc.contributor.authorLewis, Cole T.
dc.contributor.authorDiaz, Lorena
dc.contributor.authorpanesso, diana
dc.contributor.authorKaplan, Heidi B.
dc.contributor.authorBeral, Valerie
dc.contributor.authorWanger, Audrey R.
dc.contributor.authorArias, César A.
dc.date.accessioned2020-07-31T22:47:06Z
dc.date.available2020-07-31T22:47:06Z
dc.identifier.issn1098-6596spa
dc.identifier.urihttp://hdl.handle.net/20.500.12495/3644
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherAmerican Society for Microbiologyspa
dc.relation.ispartofseriesAntimicrobial agents and chemotherapy, 1098-6596, Vol. 56, Nro. 6, 2012, p. 3461-3464spa
dc.relation.urihttps://aac.asm.org/content/56/6/3461spa
dc.titleNative valve endocarditis caused by corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy?spa
dc.type.localArtículo de revista
dc.subject.decsCefotaximaspa
dc.subject.decsStaphylococcus aureus resistente a la meticilinaspa
dc.subject.decsAntibacterianosspa
dc.identifier.doihttp://dx.doi.org/10.1128/AAC.00046-12spa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.publisher.journalAntimicrobial agents and chemotherapyspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.identifier.instnameinstname:Universidad El Bosque
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourlhttps://repositorio.unbosque.edu.co
dc.title.translatedNative valve endocarditis caused by corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy?spa
dc.description.abstractenglishWe describe a patient who developed Corynebacterium striatum native valve endocarditis after receiving two 6-week courses of daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. The organism exhibited in vitro heteroresistance to daptomycin, with two subpopulations showing daptomycin susceptibility (MIC of ≤0.094 μg/ml) and high-level resistance to daptomycin (MIC of ≥256 μg/ml). The selection of daptomycin-resistant Gram-positive skin flora with the potential of causing invasive disease may be a concern during prolonged courses of daptomycin.spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abiertospa
dc.date.issued2012-03-26


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record